Suven Life Sciences (BOM:530239) E10: ₹-4.05 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:530239 Suven Life Sciences Ltd BOM:530239
41 GF Score
Price ₹306.30
GF Value ₹97.20
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Suven Life Sciences E10?

Suven Life Sciences BOM:530239 +2.24% 41 E10 is ₹-4.05 as of Mar. 2026. GuruFocus rates BOM:530239 with a GF Score™ of 41/100 and a GF Value™ of ₹97.20 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Suven Life Sciences's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹-2.020. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹-4.05 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-03), Suven Life Sciences's current stock price is ₹306.30. Suven Life Sciences's E10 for the quarter that ended in Mar. 2026 was ₹-4.05. Suven Life Sciences's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Suven Life Sciences was 258.25. The lowest was 23.07. And the median was 31.48.


Suven Life Sciences  (BOM:530239) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Suven Life Sciences was 258.25. The lowest was 23.07. And the median was 31.48.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Suven Life Sciences E10 Related Terms


Suven Life Sciences E10 Historical Data

* Premium members only.

The historical data trend for Suven Life Sciences's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Suven Life Sciences E10 Chart

Suven Life Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.80 1.89 1.14 -0.89 -4.05

Suven Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.89 -1.66 -2.51 -3.48 -4.05

BOM:530239 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Suven Life Sciences's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suven Life Sciences Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Suven Life Sciences's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Suven Life Sciences's Shiller PE Ratio falls into.


BOM:530239
41GF Score
Suven Life Sciences Ltd BOM:530239
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Suven Life Sciences E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Suven Life Sciences's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-2.02/164.2724*164.2724
=-2.020

Current CPI (Mar. 2026) = 164.2724.

Suven Life Sciences Quarterly Data

per share eps CPI Adj_EPS
201412 2.516 96.780 4.271
201503 1.161 97.163 1.963
201506 1.465 99.841 2.410
201509 1.788 101.753 2.887
201512 1.281 102.901 2.045
201603 2.681 102.518 4.296
201703 2.921 105.196 4.561
201803 0.000 109.786 0.000
201806 1.880 111.317 2.774
201809 0.276 115.142 0.394
201812 -1.041 115.142 -1.485
201903 -2.857 118.202 -3.971
201906 -1.889 120.880 -2.567
201909 -1.437 123.175 -1.916
201912 -1.649 126.235 -2.146
202003 -1.852 124.705 -2.440
202006 -0.756 127.000 -0.978
202009 -1.133 130.118 -1.430
202012 -1.769 130.889 -2.220
202103 -1.567 131.771 -1.954
202106 -2.838 134.084 -3.477
202109 -2.046 135.847 -2.474
202112 -2.500 138.161 -2.972
202203 -1.540 138.822 -1.822
202206 -1.120 142.347 -1.293
202209 -1.590 144.661 -1.806
202212 -2.900 145.763 -3.268
202303 -1.268 146.865 -1.418
202306 -1.100 150.280 -1.202
202309 -0.580 151.492 -0.629
202312 -1.920 152.924 -2.062
202403 -1.220 153.035 -1.310
202406 -1.290 155.789 -1.360
202409 -2.270 157.882 -2.362
202412 -1.790 158.323 -1.857
202503 -2.020 157.552 -2.106
202506 -2.360 159.755 -2.427
202509 -3.480 162.289 -3.523
202512 -4.550 163.281 -4.578
202603 -2.020 164.272 -2.020

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹-4.05 mean?
Suven Life Sciences (BOM:530239) has a E10 of ₹-4.05 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Suven Life Sciences and its competitors.
Is Suven Life Sciences' E10 too high?
Suven Life Sciences' current E10 is ₹-4.05. Overall, Suven Life Sciences has a GF Score™ of 41/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Suven Life Sciences' E10 compare to ZTS?
Suven Life Sciences' E10 of ₹-4.05 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Suven Life Sciences and its competitors. Suven Life Sciences's current E10 is ₹-4.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suven Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Suven Life Sciences (BOM:530239) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹97.20, compared to a current price of ₹306.30 — trading 215.1% above its estimated fair value. The current E10 is ₹-4.05. Suven Life Sciences' overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Suven Life Sciences (BOM:530239), the current E10 is ₹-4.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Suven Life Sciences (BOM:530239) Overvalued in 2026?

Based on GuruFocus' analysis, Suven Life Sciences stock appears to be overvalued. The current stock price of ₹306.30 is trading 215.1% above its estimated GF Value™ of ₹97.20. GuruFocus considers Suven Life Sciences to be Significantly Overvalued.

Key valuation signals for BOM:530239:

  • E10: ₹-4.05
  • GF Value™: ₹97.20 vs. price of ₹306.30 (215.1% above fair value)
  • GF Score™: 41/100 with 6 warning signs

No single metric tells the full story. See the BOM:530239 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Suven Life Sciences Business Description

Other Exchanges SUVEN:India
Address Avenue 7, Road No. 5, Banjara Hills, Number 8-2-334, 6th Floor, SDE Serene Chambers, Hyderabad, TG, IND, 500 034
Suven Life Sciences Ltd is an India-based biopharmaceutical company. The company is focused on the acquisition, development, and commercialization of novel therapeutics for the treatment of neurodegenerative disorders. The company's only segment is providing Research and Development services. The company's geographical segment includes India; the USA; Europe and Others. The company generates maximum revenue from the USA. The company earns revenue from the sale of New Chemical Entity (NCE) based Intermediates for CNS disorders.
41GF Score

Get the complete analysis for BOM:530239

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹306.30
Price
₹97.20
GF Value